Skip to main content

Month: June 2023

LIXTE Biotechnology Holdings, Inc. Announces 1-for-10 Reverse Stock Split of its Common Stock Effective on Pre-Market Opening on June 5, 2023

PASADENA, CA, June 02, 2023 (GLOBE NEWSWIRE) — LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT) announced today that it will effect a 1-for-10 reverse stock split of its issued and outstanding common stock effective on Friday, June 2, 2023. Commencing with the opening of trading on the Nasdaq Capital Market on Monday, June 5, 2023, the Company’s common stock will trade on a post-split basis under the same symbol LIXT. The reverse stock split was approved by the Company’s stockholders at a special meeting of stockholders held on May 26, 2023, with the final ratio being determined by the Company’s Board of Directors. As a result of the reverse stock split, the CUSIP number for the Company’s common stock will be changed to 539319301, and every 10 shares of issued and outstanding common stock will be exchanged...

Continue reading

Trisura Group Announces Results of Annual Meeting of Shareholders

TORONTO, June 02, 2023 (GLOBE NEWSWIRE) — Trisura Group Ltd. (“Trisura Group” or the “Company”) (TSX: TSU) today announced the results of the Company’s annual meeting of shareholders held on June 1, 2023 in Toronto (the “Meeting”). At the Meeting, all eight nominees proposed for election to the Board by Shareholders were elected. Management received the following proxies from Shareholders in regard to the election of directors:Director Nominee Votes For %   Votes Withheld %  David Clare 35,780,580 99.41 % 211,215 0.59 %Paul Gallagher 34,039,711 94.58 % 1,952,084 5.42 %Barton Hedges 35,781,310 99.42 % 210,485 0.58 %Anik Lanthier 35,824,923 99.54 % 166,872 0.46 %Janice Madon 35,782,370 99.42 % 209,425 0.58 %Greg Morrison 35,780,537 99.41 % 211,258 0.59 %George E. Myhal 28,752,373 79.89 % 7,239,422 20.11 %Robert...

Continue reading

CN Among Global Leaders in Sustainability

MONTREAL, June 02, 2023 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) is proud to be part of the United Nations Vision 2045 documentary film series. CN’s video highlights how the Company is moving towards a more sustainable future. CN is building on its decarbonization initiatives, its deployment of operating technologies to drive safety and efficiency, its focus on making CN a great place to work, and by engaging with all stakeholders with trust and transparency. CN’s sustainability leadership is recognized through its inclusion in the Dow Jones Sustainability World and North American Indices. CN has also been recognized for its climate leadership, securing a place on CDP’s prestigious Climate Change “A” List. “For more than 100 years, CN has been powering and growing the North American economy and we intend...

Continue reading

GAMCO Sends Letter to Telephone and Data Systems

RYE, N.Y., June 02, 2023 (GLOBE NEWSWIRE) — GAMCO Asset Management Inc. (“GAMCO”), an affiliate of GAMCO Investors, Inc. (OTCQX: GAMI), and certain other affiliates own, on behalf of their clients, approximately 4.3% of the outstanding common shares of Telephone and Data Systems, Inc. (NYSE: TDS) (the “Company” or “TDS”). Today, GAMCO sent a letter to the Company’s President and Chief Executive Officer. A copy of the letter is referenced herein. June 1, 2023Mr. LeRoy T. Carlson, Jr.President and Chief Executive OfficerTelephone and Data Systems30 North LaSalle StreetSuite 400Chicago, IL 60602 Dear Ted, We have been following TDS for nearly four decades. We currently own 4.5 million shares of TDS common stock for clients. We did not share any concerns when the Company changed the voting structure some twenty years ago. While we...

Continue reading

Microbot Medical Announces $1.5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

HINGHAM, Mass., June 02, 2023 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has entered into definitive agreements for the purchase and sale of 701,756 shares of the Company’s common stock at a purchase price of $2.1375 per share of common stock in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered series C preferred investment options. The series C preferred investment options to purchase up to 350,878 shares of common stock have an exercise price of $2.075 per share and are immediately exercisable for a period of five and one-half years following issuance. The closing of the registered direct offering and the concurrent private placement is expected to occur on or about June 6, 2023, subject...

Continue reading

DELTA DRONE – Sale of 11.20% of the stake in Donecle

Sale of 11.20% of the stake in DonecleDardilly, June 2, 2023 at 6 p.m.Delta Drone announces the sale of 11.20% of the capital of Donecle to a company formed around the management of Donecle. Following this transaction, Delta Drone will continue to hold 13.63% of the capital. This operation is part of the asset disposal program initiated several months ago. It also responds to the desire of Donecle’s main Managers to strengthen their position in the company’s capital, in line with the significant development that the company is currently enjoying. Donecle is now the worldwide leader of automated aircraft general visual inspection based on drone technology, offering a unique solution combining a 100% automated drone with advanced image analysis algorithms. About Delta Drone: The Delta Drone Group is a recognized international...

Continue reading

FuelPositive Earns Best Places to Work Award by HRD Canada, Fostering Pride and Engagement

WATERLOO, Ontario, June 02, 2023 (GLOBE NEWSWIRE) — FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) (“FuelPositive” or the “Company”), a leading Green Ammonia company, is delighted to announce its recognition as a winner of the esteemed Best Places to Work award in 2023 by Human Resources Director Canada, the world’s leading independent HR publisher. “We are immensely proud to be acknowledged as one of Canada’s best places to work. This accolade underscores the tireless efforts and unwavering dedication of our employees to our company’s mission and values. Our employees are the heart of our organization, and we are committed to fostering a supportive and inclusive workplace where they can thrive, learn, and grow,” expressed Nelson Leite, Chief Operating Officer, with deep appreciation. “FuelPositive remains...

Continue reading

Number of shares and voting rights as of April 30, 2023

EXEL IndustriesA French Société Anonyme with a share capital of €16,969,750Registered office: 54, rue Marcel Paul – 51206 Epernay Cedex – FranceReims Companies Register (RCS): No. 095 550 356 Number of shares and voting rights Article 223-16 of the AMF regulationDate Total number of shares comprising the share capital Total number of voting rightsApril 30, 20236,787,900Theoretical voting rights: 10,854,215Exercisable voting rights*: 10,849,727* After deduction of shares without voting rights AttachmentEXEL Industries Droits de vote 2023.04.30_EN

Continue reading

Theratechnologies Receives FDA Agreement to Amended Trial Protocol for its Lead PDC Candidate Sudocetaxel Zendusortide

Phase 1 trial to resume with weekly dosing, a focus on patients with ovarian cancer and refined patient selectionJune 13 call for investors and analysts with trial investigators to provide insights on safety and efficacy data presented at ASCO 2023 that informed protocol update This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated December 16, 2021, to its short form base shelf prospectus dated December 14, 2021.MONTREAL, June 02, 2023 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that the U.S. Food and Drug Administration (FDA) has agreed to the Company’s amended protocol for the Phase...

Continue reading

FLEURY MICHON : Déclaration mensuelle rachat d’actions 05 2023

CONTRAT DE LIQUIDITE ET OU PROGRAMME DE RACHATSIREN : 572 058 329 Dénomination sociale de l’Emetteur : FLEURY MICHON LEI : 96950009EM1D72NGCV27 Numéro de visa du programme: …Nature des titres (nom du titre + caractéristiques : ADP, CCI …)  : Actions Date de début du programme : …TABLEAU DE DECLARATION MENSUELLE DES OPERATIONS REALISEESPAR UN EMETTEUR SUR SES PROPRES TITRESOpérations du mois de : MAI 2023 Part de l’émetteur dans le contrat : 100%INFORMATIONS CUMULEES Nombre de titres composant le capital de l’émetteur au début du programme                  4 387 757Capital auto détenu de manière directe et indirecte au début du programme (en titres + %) :…Solde à la fin du mois précédent 1 216 567Nombre de titres achetés dans le mois          4 151Nombre de titres vendus dans le mois     ...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.